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Pancreatic Adenocarcinoma (PDAC) remains an overwhelmingly fatal disease 
with approximately 95% of patients dying within 5 years of diagnosis. Little clinical 
development has been seen despite the progress that has been made in understanding 
the molecular makeup of pancreatic cancer. The disease is so deadly because it 
metastasizes quickly and there is no effective treatment due to the dense stroma that 
protects the tumor because of an intense desmoplastic reaction. It has been found that 
the sonic hedgehog (Hh) pathway is upregulated in 70% of pancreatic 
adenocarcinomas. The sonic Hh ligand is overexpressed in the pancreatic 
adenocarcinomas and the gene coding for the ligand’s receptor, Smoothened (Smo), is 
overexpressed in cancer associated fibroblasts. This suggests that cancer associated 
fibroblasts actively communicate with PDAC tumor cells and that Hh signaling plays 
some role in PDAC progression. To study the effect of SMO and the crosstalk between 
the cancer associated fibroblasts (CAFs) and the tumor, PDAC cells were grown in 
collected conditioned media (CM) harvested from the fibroblasts. Conditioned Media 
was collected from both SmoWT or Smonull  fibroblasts. It was determined through ki67 
assays and BrdU assays that when tumor cells were grown in CM form Smonull cellular 
proliferation increased. Therefore, It was determined that the fibroblasts do 
communicate with the PDAC cells and when the Hh pathway was removed from the 
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Pancreatic Ductal Adenocarcinoma, PDAC, is one of the most deadly cancers, 
with only 5% of patients surviving five years after diagnosis and a median survival of 
less than six months (National Cancer Institute). PDAC has such a high mortality rate 
because it metastasizes so quickly and there are no effective treatments available. In 
order to treat this cancer, a better understanding of the tumor microenvironment and 
how the tumor spreads within the pancreas needs to be obtained. To address this issue, 
Dr.Ostrowski’s lab has focused on studying the tumor microenvironment and how it 
contributes to tumor growth.  
PDAC develops in a series of steps where normal pancreatic tissue transforms 
into pancreatic intra-epithelial neoplasia (PanIN). A normal human pancreas is 
composed of acinar cells and ductal cells, which are composed of cuboidal cells with 
uniform nuclei. In the first stage of PDAC development, the cuboidal cells take on a 
more columnar phenotype, this is the characteristic of PanIN-1A lesions. PanIN-1B 
lesions are characterized by papillary ductal lesions and the transition to PanIN-2 
lesions is marked by nuclear atypia and loss of cellular polarity. Finally, PanIN-3 lesions 
are characterized by  a complete loss of cellular polarity and the presence of goblet 
cells, mucous producing cells typically found in the respiratory and digestive systems 
(Hingarani et al, 2003). Importantly, during this entire tumorigenic cascade, there is a 
stepwise expansion of the stroma that correlates with disease progression. By the time 
the tumors reach PDAC stage, they can be comprised of roughly 70% stroma (Chu et 
al, 2007).  
One of the key characteristics of PDAC is the formation of a dense stroma 
(Mahadevan et al, 2007). The tumor stroma, also called the tumor microenvironment ( 
TME), is the complex system of cells,  signaling molecules, and extracellular matrix 
surrounding the tumor. The cells that typically surround the tumor are fibroblasts, 
immune cells and endothelial cells and the signaling molecules present are typically 
cytokines and growth factors. It has been found, that in PDAC the TME rapidly evolves 
during the progression of pancreatic cancer (Chu et al, 2007). The cancer associated 
fibroblasts (CAF) make up a large portion of the TME and they are thought to have a 
large role during PDAC development. The CAFs play a role in the development of the 
characteristic dense stroma of PDAC. When CAFs are activated by growth factors like 
TGFbeta-1 and platelet derived growth factor (PDGF), they secrete fibronectin and 
collagens which create a dense stroma. This dense stroma that surrounds the tumor is 
believed to result in decreased vascularization of PDAC which protects the tumor from 
chemotherapy. Additionally, CAFs are a key source of cytokines that aid the tumor-
stroma crosstalk, promoting PDAC progression and metastasis (Masamune et al, 2009). 
However, the exact mechanism of the CAF and PDAC crosstalk has yet to be studied.  
An important oncogene in PDAC development is the Kras gene; more than 90% 
of patients with pancreatic cancer have an activated Kras mutation (Hingarani et al, 
2003). The Kras gene codes for the KRAS protein, which serves an important function 
in the cellular pathway that controls cellular division (US National Library of Medicine).  
Kras is part of the Ras family which is a signaling transducing GTPase. When mutated, 
they leave the protein in its GTP-bound form and therefore it constitutively interacts with 
the downstream effector proteins (Lee et al, 2010). Therefore, When Kras is 
overexpressed, cellular division increases. The Kras mutant that we use in our lab is the 
KrasG12D variant, which is found in nearly all PDAC patients and is a constitutively active 
form of the protein.  Another common mutation in human PDAC, is the inactivation of 
the tumor suppressor gene P53, which is found to be mutated in 70% of PDAC patients.  
(Kimmelmen et al, 2006)  
Another important pathway observed to be over-activated in human PDAC is the 
hedgehog (Hh) signaling pathway. The Hh pathway, which plays an essential role in 
regulating cell proliferation and differentiation during the embryonic stage of 
development, is not normally expressed in adult tissue (Walter et al, 2010). However, it 
has been found that the Hh signaling pathway is re-activated in 70% of patients with 
PDAC (Walter et al, 2010). The three main Hh proteins in humans are sonic, Indian, and 
Desert (Walter et al, 2010). The ligands serve to activate the Hh pathway in neighboring 
cells through cellular crosstalk. In humans, the Hh ligands bind to Patched1 protein 
(PTCH1) on target cells, which release the suppression of smoothened (SMO), the key 
transducer of Hh pathway. Activated SMO relocates to the cilia membrane and initiates 
an intracellular down-stream signaling cascade, resulting in activation of GLI 
transcription factors and expression of downstream targets such as Gli1, Ptch1 and C-
myc. Furthermore, it has been shown that Hh signaling promotes pancreatic 
tumorigenesis through a paracrine manner. However, the target cell compartments 
remain unclear (Ming et al, 1998;Katoh et al 2009). More evidence has indicated that 
Hh in CAFs is responsible for PDAC progression. When Smo inhibitors were treated on 
a mouse model, there was a reversal of the tight fibrotic stroma (Olive et al, 2009). 
However, recent phase II clinical trial of SMO inhibitor IPI-926 in combination with 
Gemcitabine on PDAC resulted in a worse prognosis when compared to placebo groups 
(Infinity Corp reports, 2012). Therefore, the specific role of Hh mediated crosstalk 
between pancreatic tumor and stromal fibroblasts need to be elucidated to provide 
directions for future clinical works.  
In order to study pancreatic cancer, a mouse model that mimics human PDAC 
development, has a similar genetic makeup, and mimics the tumor microenvironment 
and dense stroma of human PDAC needs to be used. Our lab uses a 
Mist1Kras:FspCreSmoloxp (Mist1) system. The presence of a mutated Kras within Mist1, 
a gene expressed during pancreatic development in the acinar cells, causes the 
development of mixed ductal and acinar carcinomas that mimic the human condition. 
This mouse model, because of the fibroblast specific Cre Recombinase, allows the 
selective removal of Smo from fibroblasts. Thus we are able to knockout SMO 
specifically in the fibroblasts of a Kras-driven pancreatic tumor model to study the roles 
of Hh signaling during tumor formation. Preliminary results, comparing the in vivo 
microenvironment of precancerous cells with fibroblasts with SmoWt and Smonull, show 
that there is more cellular proliferation in the ductal cells of the Smonull group. Also, it 
was found that there was increased cellular proliferation within the fibroblasts that 
lacked Smo (Wu et al, unpublished). This preliminary data indicates that without Smo 
both the fibroblasts and precancerous ductal cells proliferate at a higher rate.  My 
project will seek to determine if late stage tumor cells will exhibit the same increase in 
proliferation without Smo as the precancerous lesions. To test this, a LSL-KrasG12D/+ ; 
TP53R172H/+ PdxCre (KPC)  mouse model, which does cause development of full PDAC 
in mice, will be used. In this model, a mutated Kras and a nonfunctioning p53 will be 
introduced into pancreatic cells, resulting in the development of PDAC in mice. Also, I 
will seek to determine the effect that the CAFs alone, without the presence of other cells 
in the microenvironment, will have on the proliferation of PDAC cells. The overarching 
hypothesis of this project is that the deletion of the hedgehog pathway in the 
tumor associated fibroblast promotes tumor growth.    
 
 
Specific Aims:  
1. To determine if cancer associated fibroblasts are a source of tumor-stroma 
crosstalk.  
2. To study the effect of Smo deleted fibroblasts on tumor growth through in vitro 
growth of PDAC cells with conditioned media from fibroblasts. 











4. Materials and Methods 
4.1  Mist1Kras; FspCre; Smoloxp 
A mutated Kras, KrasG12D , is expressed in Mist1, a transcription factor that is 
expressed during Pancreatic development and necessary for proper pancreatic acinar 
organization. Smo was deleted from the fibroblasts by flanking the Smo gene with two 
loxp sites. These sites are recognized by FspCre, a DNA recombinase specific to 
fibroblast cells, which cuts the DNA at the two loxp sites and recombines the DNA. This 
completely removes the Smo gene from the mouse DNA. The ultimate genotype is: 
Mist1-Kras;FspCre;Smoloxp .  
4.2 KPC mouse model 
The cancer cells were obtained from mice with a null tumor suppressor p53R172H 
allele and loxp sites around the regulatory stop site in front of the mutated KrasG12D 
gene. The Cre is inserted in the elastase pancreatic promoter, so it is only expressed in 
pancreatic cells. The cre is also placed in the elastase promoter with the human 
estrogen receptor, so that the Cre is only able to be induced when the synthetic ligand 
4-hydroxytamoxifen is present. When Cre is active, it removes the stop site in front of 
the Kras gene, causing  the mutant Kras to be expressed in pancreatic cells with no 
regulation. The loxp sites also flank a regulatory stop site in front of the null p53 allele. 
When the cre recombinase cuts and recombines the loxp sites, the null p53 allele is 
expressed. The ultimate genotype is: Elas-CreER; LSL-KrasG12D/+ ; TP53R172H/+ . There 
are three cell lines utilized in this study; KC, KPC1, and KPC2. Both KPC cell lines were 
obtained from PDAC tumors have the genotype listed above. KC does not contain the 
mutant p53 allele but has the activated Kras giving it the ultimate genotype of  Elas-
CreER; LSL-KrasG12D/+ . The KC cell line was derived PanIN-like lesions, not PDAC 
tumors. These cells were generously donated from Stephen F.  Konieczny at Purdue 
University. 
4.3 Genotyping 
 In the Smo mouse model, a polymerase chain reaction (PCR) was run to check 
that FspCre is present in the experimental group. PCR was also used to ensure that 
mutant Kras is expressed in both the control and experimental group. Also, it is needed 
to check for the presence of the loxp sites that flank the Smo gene. In order to isolate 
the genes, primers specific and antisense to the genes DNA sequence was used. In 
addition to primers, a buffer mix, sample DNA, dNTPs, and Taq polymerase (biolabs 
M0267L) were added to allow for the amplification of the desired gene.  
SmoLoxP: 
SmoLoxP forward: TGCGCTACAACGTGTGCCTG   
SmoLoxP reverse 1: GGCGCCTACCGGTGGATGTGG  
SmoLoxP reverse 2: CCGGTGGATGTGGAATGTG 
  
For Smo+/-:  
SmoForward: GCAAAGTTGGGAGTCGAG  
SmoReverse: CCAAACAGCCAACTCAGC 
SmoNullreverse: ATTTGTCACGTCCTGCAC  
  
MistKras: 
Mist1-Kras forward: AGGTGTCCACTAAGCACCAGT  




nFspCreForward: CGTGGGTTGGAGAATGTTAC  
nFspCre Reverse1:ATTTCTAGTGCCCATCTCCG  
nFspCre Reverse 2: CCGGTTATTCAACTTGCACC 
 
 
4.4 Fibroblast Isolation 
A dissected pancreas is minced in collagenase and then mixed with digestion 
solution ( Pbs, collagenase Type II, DNase I). The tissue is then placed on a shaker at 
37 degrees Celsius for 60 minutes at 225 rpm. The vial is spun down and the 
supernatant is removed and the tissue is plated on a 6 well plate in Dulbecco’s Modified 
Eagle Medium (DMEM) (wu et al, unpublished).  
 The effectiveness of the isolation was tested through a Smooth Muscle Actin 
(SMA), Vimentin, and Yellow Fluorescent protein (YFP) stain. Both SMA and Vimentin 
are fibroblasts specific stains. The YFP is placed into the chromosome and then 
expressed in the fibroblasts alone because of an FspCre. Therefore, the presence of 
YFP can serve as a fibroblasts specific marker.  
 
4.5   Conditioned Media 
 In order to grow cells in media with the extracellular components released by 
fibroblasts, the media the fibroblasts are grown in must be collected. This is called 
conditioned media (CM). Conditioned media from both SmoWT and Smo null fibroblasts 
was collected. 
 Fibroblasts were grown to 80% confluency and then washed twice with 
Dulbecco’s Phosphate Buffered Saline (DPBS) and serum free media. Then serum free 
media was placed on the cells for 36 hours. After 36 hours, the media was sucked off, 
spun down, and filtered through a 0.2 um  Thermo Scientific Nalgene Syringe Filter. The 
media is then stored at -20 degree Celsius. Then when the experiments are performed, 
fetal bovine serum (FBS) is added so that the CM is at 0.5% FBS.   
 4.6  Growth Curve 
Each growth curve was performed on a 12 well plate, so that each count for a single 
day was performed three times, and those numbers were averaged to give the cell 
count for each day. The fibroblast growth curve was performed at passage 12, the cells 
were plated at 3,000 cells per well and the experiment was performed for eight days. 
The tumor cell growth curve was performed at passage 14, were plated at a starting 
concentration of 2,000 cells per well and it was performed for eight days.  
 
4.7 Immunofluorescent Staining Protocol 
All three cell lines, KC, KPC, and KPC2, were used in both the 
Bromodeoxyuridine (BrdU) and Ki67 stainings. Each time a staining was performed, all 
three cell lines were at the same passage number and the staining was performed at 
the same time with the same batch of conditioned media. For each type of staining, 
there was a baseline experiment performed in regular DMEM media with 10% FBS and 
0% FBS. Then a conditioned media experiment was performed for each stain with both 
experimental and control conditioned media, both with 0.5% FBS. Each cell line was 
plated at 15,000 cells per well in regular media and 10,000 cells per well with the 
conditioned media. Also, each cell line was plated in four wells.  
Ki67 is a cellular protein that is found on replicating cells, and therefore can serve 
as a marker for proliferation. The protocol for the staining performed in regular DMEM 
media, is as listed above and the experiment was performed when all three cell lines 
were at passage 23. For the conditioned media experiments, the cells were washed and 
counted in FBS free media, then plated in conditioned media with 0.5% FBS. Ki67 anti-
rabbit (abcam ab15580) was placed on the cells at a dilution of 1:100 for 2 hours and a 
fluorescent secondary was placed on the cells at a dilution of 1:25 for 1 hour. All cell 
lines were at passage 23 when this experiment was performed.   
 Each slide was photographed four times, and with four wells per cell line, there 
were sixteen pictures per cell line in each different condition, DMEM, control CM, and 
experimental CM. The pictures were taken on a fluorescent microscope and the cells 
positive for Ki67 were counted using Image J. The total cells positive for Ki67 were 
compared to the total cells, stained with DAPI, to get a percentage of positive cells to 
total ((100%)(Ki67+/total DAPI+)). A ttest was performed to determine p-value.  
 
4.8   BrdU  
Bromodeoxyuridine is a synthetic nucleotide that incorporates itself into 
replicating genomes and therefore it can serve as a marker for replicating cells. Again 
with regular media cells were plated at 15,000 cells per well and each cell line had four 
wells. The cells were plated at passage 14. Stainings performed with CM, had cells 
plated at 10,000 cells per well in four wells and all three cell lines were at passage 20. 
DMEM staining was performed as stated above. For the CM experiments, cells were 
washed and counted in serum free media and plated with CM with 0.5% FBS.  
 BrdU was placed on the cells for 8 hours. The cells were then fixed and BrdU 
anti-mouse (calbiochem NA61) was placed on the cells at a concentration of 1:100 for 
two hours. Then a fluorescent secondary was placed on the cells for 75 minutes at a 
concentration of 1:75.  
Each slide was photographed four times for a total of sixteen pictures per cell line 
per experiment. The pictures were taken on a fluorescent microscope and counted on 
Image J. All the BrdU positive cells were counted then compared to the total cells, ones 
that were positive for DAPI ((100%)(BrdU+/#DAPI)). A ttest was performed to determine 
the p-value. 
  
4.9 Tissue Staining  
Tissues were fixed in 10% neutral buffered formalin, paraffin-embedded and five 
micron sections prepared. They were rehydrated and stained with hematoxylin and 
eosin (H&E). An H&E is performed in order to view the cytoplasm and nuclei of cells. A 
trichrome stain was also performed on the same section of tissue. The cellular nuclei 
and cytoplasm and collagen was visible after a trichrome stain. Lastly, an 
immunohistochemistry stain was performed on the same tissue sample with Vimentin 
and K19. Vimentin is a fibroblast specific stain and K19 is an epithelial specific stain. 
The stain was performed with Vimentin anti-rabbit (cell signaling 5741S) at a 
concentration of 1:100 and K19 anti-rat (Troma-III-c) at a concentration of 1:200 
overnight. Then a fluorescent secondary at a concentration of 1:300 was placed on the 













5.1 Tumor Characterization 
As previously stated, PDAC is known for having a very dense stroma. The 
stroma consists mainly of fibroblasts and signaling molecules such as cytokines and 
growth factors.  In order to view the stroma, we performed H&E and Trichrome stainings 
of WT and Mist1Kras;FspCre;Smoloxp/+ (KCS) pancreatic tissue were performed, the 
difference in microenvironment becomes very evident (Figure 1A-B). The Mist1Kras 
pancreatic tissue has PanIN lesions and collagen around the ducts. Collagen 
contributes to the characteristic dense stroma of PDAC. The WT pancreatic tissue has 













Figure 1. Mist1Kras expression results in PanIN lesions and formation of a dense stroma 
A. H&E or Hematoxylin and eosin, stains for the nuclei and cytoplasm respectively. B. The trichrome 
stain allows visualization of the collagen, cytoplasm, and the nucleus.  
A B 
An immunoflourescent stain was then performed in order to determine the type of 
cells that surrounded the ducts.  The tissue was stained for the presence of fibroblasts 
with Vimentin (green), epithelial cells with K19 (red), and all cells with DAPI (blue) 
(Figure 2A-B). It was predicted that more fibroblasts would be found around the PanIn 











As evidenced by the tissue stainings, the Mist1Kras pancreases have 
significantly more ducts, and have more collagen, and more fibroblasts surrounding the 
PanIn lesions.   
5.2 Mist1Kras Mouse model 
In order to study the CAFs with and without Smo, a mouse model needed to be 
created that could effectively delete Smo from only fibroblasts. We placed loxp sites 
around the Smo gene in the Smonull  mice and  used a fibroblasts specific Cre, FspCre, 
to cut at the loxp sites and remove the Smo gene (Figure 3A).  PCR was performed to 
ensure that FspCre, Kras, and loxp sites were present (Figure 3B). As predicted, in the 
Mist1Kras mice, in vivo the pancreas was inflamed and had the characteristic shape 
Figure 2. Mist1Kras Mouse Model has increased CAF 
Cellular composition of WT and Mist1Kras Cells. Fibroblasts are visible through 
vimentin staining (green) and epithelial cells are visible through K19 staining (red).  
A B 
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 genetic model. 
A. Allelic representation of the mouse model.  B.PCR was performed to confirm the 
presence of Fsp-Cre, Kras, Loxp, and Smo genes. C.Images of dissected mouse 
pancreases from a WT mouse and a Mist1-Kras;Fsp-Cre;Smoloxp/+ mouse.  
 
 
The growth characteristics of the SmoWT and Smonull  in vitro was studied through 
a growth curve experiment and it was found that the absence of Smo does not affect the 































Figure4. Growth Characterization of Mist1Kras;Smoloxp/+ and 
Mist1Kras;FspCre;Smoloxp/+ 
A seven day growth curve experiment was performed to characterize the growth of the 
control and experimental fibroblasts.  
 
Figure 5. Elas-CreER; LSL-KrasG12D/+; TP53 R172H/+  Mouse Model 
A Allelic representation of the PDAC genetic model. B. Growth Curve of the three 
experimental PDAC cell lines for a length of eight days. 
5.3 KPC Mouse Model 
In order to study late stage cancer cells, a different mouse model was used. This 
model had a mutated Kras and a non functioning P53 (Figure 5A). Two cell lines were 
obtained from PDAC tumors and the third was obtained from PanIn lesions. The growth 
rate was determined in vitro through a growth curve experiment. It was found that the 


























In order to determine if CAFs are the main source of tumor-stromal crosstalk, a 
pure fibroblasts culture will need to be isolated from the pancreas. We have optimized a 
technique to harvest fibroblasts that has produced cultures that are 99% pure as 
measured by Smooth Muscle Actin and Vimentin, both markers for fibroblasts. Also, cell 
stainings of our fibroblasts cultures are 0% positive for cytokeratin 8 (K8), an epithelial 
marker (Figure 6). To further prove that a pure fibroblasts culture was obtained, we bred 
a cohort of mice to have a fibroblasts specific Collagen 1 Yellow Fluorescent Protein 
and used the fluorescence as a way to prove that only fibroblasts existed in our culture. 






















Smooth Muscle Actin Staining 
Kras;Col1YFP  
Vimentin Staining 
Figure 6. Confirmation of pure fibroblasts culture 
A. Images of fibroblast at 4X magnification stain for fibroblast specific markers 
SMA and Vimentin. The last stain is for YFP, which was genetically recombined 
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5.5 Cellular Proliferation 
As predicted all three cell lines, both the cells form precancerous lesions (KC) 
and cancerous epithelial cells (KPC1 and KPC2), had increased cellular proliferation 
when grown in CM from fibroblasts without Smo. Cellular proliferation rates were 
determined through BrdU and Ki67 stainings (Figure 7A-B; Figure 8A-B). The cells 
proliferation increased by about  20% when grown in CM from fibroblasts without Smo 
when compared to cells grown in CM from fibroblasts with Smo. When there are no Hh 
ligands involved in crosstalk between the tumor and stroma and therefore the Hh 
pathway is not activated in the CAFs, the tumor cells proliferation increased. The growth 
was increased so much, that when grown in CM with only 0.5% FBS, cellular 
proliferation was completely restored to cellular proliferation levels in regular 10% 
media. There was no growth associated with cells that were plated in 0% DMEM media, 
because the cells did not sit down on the plate, so a stain was not possible. These were 




























Figure 7. Conditioned Media from Smonull  fibroblasts increased tumor cell 
proliferation in vitro 
A. Representative pictures of Cell lines KC, KPC1, and KPC2 stained for BrdU after 
growth in 10% DMEM, and 0.5% control and experimental CM. B. Qantified data of BrdU 
positive cells.   
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Figure 8. Conditioned Media from Smonull fibroblasts increased tumor cell 
proliferation in vitro 
A. Representative pictures of Cell lines KC, KPC1, and KPC2 stained  for Ki67 after 
growth in 10% DMEM, and 0.5% control and experimental CM. B. Qantified data of 










6. Discussion:  
Fibroblasts were determined to play a role in the formation of the dense stroma 
surrounding PDAC. In vivo data characterizing the pancreas of Mist1Kras mice showed 
that PanIn lesions were present and they had increased presence of fibroblasts and had 
large amounts of collagen surrounding the PanIn lesions. The collagen was produced 
by the CAFs and it results in a “stromal fortress” around the PDAC.  
 Hh Signaling, an important role in embryonic development, has shown to be 
important in PDAC development. In vivo when Smo was removed from fibroblasts 
around precancerous lesions, both the epithelial cells and fibroblasts had increased 
cellular proliferation. Smo, also has an effect in vitro on the growth of precancerous and 
cancerous epithelial cells. When both the precancerous cells (KC) and cancerous cells 
(KPC1, KPC2) were grown in CM from fibroblasts with Smo and without Smo, the cells 
in the CM with Smo had a 20% increase in cellular proliferation rates. When the Smo 
receptor is not present in the fibroblasts, the Hh ligand is no longer effective in the 
tumor-stroma crosstalk, and therefore the Hh pathway is blocked in the fibroblasts. 
Therefore, the Hh pathway, when present in fibroblasts, decreases cellular proliferation 
rates and when the Hh pathway is not present in the CAFs cellular proliferation 
increases. This further indicates that the fibroblasts have a role in the tumor-stroma 
crosstalk. Also, the deletion of Smo has the same effect on both precancerous epithelial 
cells and cancerous epithelial cells, because the same increase in cellular proliferation 
was found in both cell types. 
 For future studies, the in vivo effects of Smo deleted CAFs on cancerous 
epithelial cells could be studied through a co-injection study. A co-injection of 
fibroblasts, both SmoWt and Smonull , and cancerous mouse epithelial cells could be 
performed to study the effect on tumor size. Eventually the study could be performed 
using human cells to make it more applicable to human PDAC. Based on results 
presented in this manuscript, we would predict that tumor size would increase in size 
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